Disposable Endoscopes Market Size, Share & Trends Analysis Report By Application (Bronchoscopy, Proctoscopy, Arthroscopy), By End Use (Hospitals, Clinics), And Segment Forecasts, 2018 - 2025

Industry Insights

The global disposable endoscopes market size was valued at USD 414 million in 2017. It is projected to expand at a CAGR of 26.9% during the forecast period. Rising incidence of nosocomial infections due to use of contaminated endoscopes is a key factor driving the adoption of disposable endoscopes. According to a research study conducted by the American Journal of Infection Control, microbial growth was detected in 71.0% of the endoscope samples collected from three U.S. hospitals in 2018

Increasing number of approvals from regulatory bodies including the U.S. FDA and CE marking are boosting the availability of single use scopes in the market, which in turn is positively influencing the growth of the market. For instance, in 2018, Ambu A/S received FDA clearance for single-use colonoscopes for its sale in the U.S. market. Growing concerns of regulatory bodies about safety of reusable scopes is one of the significant factors that reinforce the rise in number of product approvals.

Recent technological advancements in disposable endoscopes are boosting the demand for these products. For instance, Ambu A/S recently launched aScope4 Broncho, which provides ease in navigation through its precise tip motion and high bending angles. It is lightweight and ergonomically designed that makes it easy to use. It offers high quality images, ensures patient safety and is available in three different sizes. Another instance is SIGMOLUX, a single use sigmoidoscope of Griffiths and Nielson Ltd., which is disposable and self-illuminating endoscopy device. It is integrated with an insufflator that inflate bowel with a lens to improve its visualization.

Surging demand for low cost endoscopy procedures may contribute towards high adoption of single use endoscopes. Price of flexible scopes includes cost of equipment as well as cost of device maintenance and reprocessing. In addition, hospitals and clinics have to purchase sophisticated cleaning equipment and chemicals for decontamination of devices, which further add up to the total procedural cost. The overall cost of reprocessing ranges from USD 114.07 to USD 280.71 for one endoscope.

Increasing incidence of reprocessing failures and non-compliance to reprocessing guidelines is also providing a fillip to the market. For instance, an article published in Nursing Times reported that according to the U.S. infection control experts, the current procedures used for cleaning reusable endoscopes were ineffective.

Application Insights

In 2017, bronchoscopy accounted for the highest share in the market. Factors such as increased device availability and rise in the number of bronchoscopes related infections are contributing to the growth of the segment. In addition, high price of single use bronchoscopes in comparison to scopes used for other applications led to significant revenue generation of the segment in 2017.

Technological advancements in disposable bronchoscopes are expected to boost their demand over the forecast period. For instance, Neoflex bronchoscope of Neoscape, Inc. has built in micro LED light source and CMOS imaging sensor that captures video images of the target site. In addition, Ambu A/S is continually investing in improvement of its disposable bronchoscopes. It had launched a series of aScope including aScope 2 Broncho, aScope 3 Broncho, and aScope 4 Broncho from 2009 to 2017.

Urologic endoscopy is projected to post the highest CAGR of 28.3% during the forecast period. Recent FDA approval for single use cystoscopes and advancements in ureteroscope are anticipated to drive the growth of the segment over the coming years. Growing prevalence of post ureteroscopy infection is one of the important factors that is augmenting the demand for single use ureteroscope, which in turn resulted in their increased market revenue in 2017. According to a case study published by the Association of Perioperative Registered Nurses (AORN) in 2016, five reusable ureteroscopes were reported to be contaminated by gram-positive bacteria after ureteroscopy.

End-use Insights

In 2017, hospitals accounted for the largest revenue share in the disposable endoscopes market owing to increasing incidence of hospital-acquired infections due to contaminated endoscopes. Moreover, rising number of reprocessing failures is resulting in increased adoption of disposable endoscope among hospitals. For instance, in 2015, FDA reported that duodenoscopes was associated with infections caused from multi-drug resistant bacteria in the U.S. hospitals.

Burgeoning demand for low-cost endoscopy procedures in hospitals is also providing an upward push to the demand for the product. Reprocessing of contaminated endoscopes is a costly affair that may shift the preference of healthcare professionals towards the use of disposable ones. However, disposable endoscopes are likely to generate medical waste, which may hamper their demand among healthcare settings.

Clinics are expected to experience the highest growth during the forecast period. The segment is poised to exhibit a CAGR of 28.4%. Endoscopy procedures using flexible scopes have the potential of patient-to-patient transmission of infection in clinics, which is estimated to benefit the demand for disposable endoscopes. For instance, a case study published by the Association of periOperative Registered Nurses (AORN) in 2016 reported that improper reprocessing of scopes and accessories was the cause for transmission of hepatitis C virus in two patients, who visited the clinic for colonoscopy procedure.

Regional Insights

North America held the leading revenue share in 2017. Increasing incidence of hospital-acquired infections as a result of contaminated endoscopes is responsible for growth in the demand for disposable endoscopes in this region. High prevalence of nosocomial infections in the U.S. hospitals is estimated to be one of the major reasons for the rise in adoption of disposable endoscopes.

Presence of technologically advanced disposable endoscopes, rising number of the U.S. FDA approvals, and high healthcare expenditure are among the primary factors driving the regional market. In addition, higher adoption and awareness of disposable endoscopes among healthcare providers and patients is likely to further impel the demand for these scopes in the region.

Asia Pacific is expected to witness a CAGR of 29.0% during the forecast period. Lack of proper reprocessing procedures and growing prevalence of nosocomial infections are supplementing the growth of the regional market. According to an article published in Open Journal of Obstetrics and Gynecology in 2016, the risk of healthcare-associated infections were estimated to be two to twenty times higher in developing countries than the developed ones.

Disposable Endoscopes Market Share Insights

Ambu A/S; Hill Rom Holdings, Inc.; Boston Scientific Corporation; OBP Medical Corporation; and Flexicare Medical Ltd are some of the key players operating in this market. Players have been engaging in mergers and acquisitions to expand their product portfolio. For instance, in 2017, Ambu A/S announced the acquisition of invendo medical GmbH to enter into the market for single use GI endoscopy devices. Similarly, in 2015, Hill Rom Holdings acquired Welch Allyn to incorporate a diverse platform of disposable scopes into their portfolio. Companies are also continuously investing in technological product advancements to compete in this market.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the global disposable endoscopes market report on the basis of application, end use, and region:

• Application Outlook (Revenue, USD Thousand, 2014 - 2025)

  • Bronchoscopy

  • Urologic endoscopy

  • Arthroscopy

  • GI endoscopy

  • Proctoscopy

  • Others

• End-use Outlook (Revenue, USD Thousand, 2014 - 2025)

  • Hospitals

  • Diagnostic centers

  • Clinics

• Regional Outlook (Revenue, USD Thousand, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

  • Asia-Pacific

    • China

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • Middle East Africa

    • South Africa